The Peutz-Jeghers kinase LKB1 suppresses polyp growth from intestinal cells of a proglucagon-expressing lineage
Year: 2014
Type: article
Abstract: Liver kinase B1 (LKB1; also known as STK11) is a serine/threonine kinase and tumour suppressor that is mutated in Peutz-Jeghers syndrome (PJS), a premalignant syndrome associated with the development of gastrointestinal polyps. Proglucagon-expressing enteroendocrine cells are involved in the control of glucose homeostasis and the regulation of appetite through the secretion of gut hormones such as glucagon-like peptide-1 (GLP-1) and peptide tyrosine tyrosine (PYY). To determine the role of LKB1 in these cells, we bred mice bearing floxed alleles of Lkb1 against animals carrying Cre recombinase under proglucagon promoter control. These mice (GluLKB1KO) were viable and displayed near-normal growth rates and glucose homeostasis. However, they developed large polyps at the gastro-duodenal junction, and displayed premature mortality (death from 120 days of age). Histological analysis of the polyps demonstrated that they had a PJS-like appearance with an arborising smooth-muscle core. Circulating GLP-1 levels were normal in GluLKB1KO mice and the polyps expressed low levels of the peptide, similar to levels in the neighbouring duodenum. Lineage tracing using a Rosa26tdRFP transgene revealed, unexpectedly, that enterocytes within the polyps were derived from non-proglucagon-expressing precursors, whereas connective tissue was largely derived from proglucagon-expressing precursors. Developmental studies in wild-type mice suggested that a subpopulation of proglucagon-expressing cells undergo epithelial-mesenchymal transition (EMT) to become smooth-muscle-like cells. Thus, it is likely that polyps in the GluLKB1KO mice developed from a unique population of smooth-muscle-like cells derived from a proglucagon-expressing precursor. The loss of LKB1 within this subpopulation seems to be sufficient to drive tumorigenesis.
Source: Disease Models & Mechanisms
DOI: 10.1242/dmm.014720
Institutions: Imperial College London, University of Cambridge
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,291
Funders: Eli Lilly and Company, Wellcome Trust, National Institute for Health and Care Research, Diabetes UK, Imperial College London, European Foundation for the Study of Diabetes, Medical Research Council, Biotechnology and Biological Sciences Research Council, NIHR Imperial Biomedical Research Centre, FP7 Health
Awards: G1258311730, G1261368593, G1635243398, Understanding pancreatic beta cell dysfunction in diabetes., Roles of GWA genes in controlling pancreatic beta cell function and mass., G2040450235, G2070628562, NIHR Senior Investigator Award, Control of glucagon secretion by AMPK and related kinases., How the brain controls food intake: the emerging role of the brain GLP-1 system in energy balance and autonomic control, How the brain controls food intake: the emerging role of the brain GLP-1 system in energy balance and autonomic control, G3555667338, NIHR Senior Investigator Award, G4913331713, G5244405737, Centre for Integrative Physiology and Pharmacology at Imperial, G5945015351, G7712152596, Enteroendocrine cell function in diabetes and obesity., G978682529
OpenAlex ID: W2114742607
